(RTLX, IBIO, GVP) CRWENewswire Stocks In Action

For the fourth quarter of 2011, Retalix Ltd - RTLX - posted total revenues of $62.5 million, a 16.2% increase year over year. GSE Systems Inc - GVP - announced new contracts valued at approximately $8.0 million involving nuclear, fossil, and process simulation, tutorials, and consulting services. Each of these projects was awarded during the first quarter of 2012. iBio Inc - IBIO - reported issuance of a US patent covering the use of iBio s proprietary fusion-protein technology in combination with influenza virus antigens for vaccine product applications.*********************THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! (Read Full Disclaimer at http://crwenewswire.com/disclaimer ).

http://www.nicovideo.jp/watch/sm17118200